Showing results (1-10 of 1,502) with videos related to
Sort By:
Pageof 151
The Journal of Nutrition, Health & Aging|April 29, 2010
IPECAD5--Fifth International Pharmaco-Economic Conference on Alzheimer's DiseaseA Gustavsson, L Jonsson, H Fillit, et al.Dementia and Geriatric Cognitive Disorders|January 13, 2006
An estimate of the worldwide prevalence and direct costs of dementia in 2003A Wimo, L Jonsson, B WinbladThe Journal of Nutrition, Health & Aging|October 6, 2010
Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS studyA Gustavsson, L Jonsson, T Rapp, et al.Alzheimer Disease and Associated Disorders|January 6, 2000
Assessing the societal impact of acetylcholinesterase inhibitor therapiesB Winblad, A WimoCurrent Pharmaceutical Design|February 3, 2004
Economic aspects on drug therapy of dementiaA Wimo, B WinbladInternational Journal of Geriatric Psychiatry|July 2, 1999
The social consequences for families with Alzheimer's disease patients: potential impact of new drug treatmentA Wimo, B Winblad, M GrafstromDementia and Geriatric Cognitive Disorders|September 6, 2000
Outcome measures in Alzheimer's disease: do they go far enough?B Winblad, A Wimo, O AlmkvistInternational Journal of Geriatric Psychiatry|August 1, 1997
Costs of dementia and dementia care: a reviewA Wimo, G Ljunggren, B WinbladClinical Therapeutics|July 15, 1998
Economic impact of introducing propentofylline for the treatment of dementia in SwedenA Wimo, E Witthaus, M Rother, et al.The Journal of Nutrition, Health & Aging|October 6, 2010
The Resource Utilization in Dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementiaA Wimo, L Jonsson, A ZbrozekPageof 151